Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Van Dijk, Peter R ^a   Kramer, Anneke ^b   Logtenberg, Susan J J ^a,c   Hoitsma, Andries J ^d,e   Kleefstra, Nanne ^a,c   Jager, Kitty J ^b   Bilo, Henk J G ^a,c,f  

^a Diabetes Centre   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RENINE Registry   (Netherlands)

^f Department of Internal Medicine ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; GLOMERULOSCLEROSIS; HEMODIALYSIS; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; POPULATION; PREVALENCE; REGISTER; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; DIABETIC NEPHROPATHIES; FEMALE; MALE; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INCIDENCE; MALE; NETHERLANDS; PREVALENCE; REGISTRIES; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS;

EID: 84922384847     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005624     Document Type: Article

References (28)

1. Gall MA, Nielsen FS, Smidt UM, et al. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993;36: 1071-8.
2. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006;17: 2275-84.
3. Stel VS, van de Luijtgaarden MWM, Wanner C, et al. The 2008 ERAEDTA Registry Annual Report-A précis. NDT Plus 2011;4: 1-13.
4. Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012;59: A7, e1-420.
5. Hill CJ, Fogarty DG. Changing trends in end-stage renal disease due to diabetes in the United Kingdom. J Ren Care 2012;38(Suppl 1): 12-22.
6. Assogba FGA, Couchoud C, Hannedouche T, et al. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia 2014;57: 718-28.
7. Grace BS, Clayton P, McDonald SP. Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy. Nephrol Carlton Vic 2012;17: 76-84.
8. De Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011;305: 2532-9.
9. Sørensen VR, Hansen PM, Heaf J, et al. Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark. Kidney Int 2006;70: 187-91.
10. Houweling ST, Kleefstra N, Meulepas M, et al. New estimates of diabetes prevalence in the Netherlands, based on information from 5 million subjects (DUDE-1). Diabetologia 2013;56: 291.
11. Baan CA, Bonneux L, Ruwaard D, et al. The prevalence of diabetes mellitus in the Netherlands: A quantitative review. Eur J Public Health 1998;8: 210-16.
12. de Charro FT, Ramsteyn PG. RENINE, a relational registry. Registratie Nierfunctievervanging Nederland. Nephrol Dial Transplant 1995;10: 436-41.
13. Van Dijk PCW, Jager KJ, Stengel B, et al. Renal replacement therapy for diabetic end-stage renal disease: Data from 10 registries in Europe (1991-2000). Kidney Int 2005;67: 1489-99.
14. Van Dijk PC, Jager KJ, de Charro F, et al. Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001;16: 1120-9.
15. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 2000;19: 335-51.
16. http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL& PA=37713&HD=140429-1042 (accessed 1 May 2014).
17. van Hateren KJJ, Drion I, Kleefstra N, et al. A prospective observational study of quality of diabetes care in a shared care setting: Trends and age differences (ZODIAC-19). BMJ Open 2012;2: Pii: E001387.
18. Parving H-H, Hovind P. Microalbuminuria in type 1 and type 2 diabetes mellitus: Evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy. Curr Hypertens Rep 2002;4: 387-93.
19. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, et al. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol 2003;18: 793-800.
20. Lutgers HL, Gerrits EG, Sluiter WJ, et al. Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10). PLoS ONE 2009;4: E6817.
21. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63: 225-32.
22. Jassal SV, Kelman EE, Watson D. Non-dialysis care: An important component of care for elderly individuals with advanced stages of chronic kidney disease. Nephron Clin Pract 2011;119(Suppl 1): C5-9.
23. Crail S, Walker R, Brown M, et al. Renal supportive and palliative care: Position statement. Nephrol Carlton Vic 2013;18: 393-400.
24. Gansevoort RT, van der Heij B, Stegeman CA, et al. Trends in the incidence of treated end-stage renal failure in the Netherlands: Hope for the future? Kidney Int Suppl 2004: S7-10.
25. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010;33: 73-7.
26. International Diabetes Federation. IDF diabetes atlas. 5th edn. Brussels, Belgium: International Diabetes Federation, 2011.
27. Lok CE, Oliver MJ, Rothwell DM, et al. The growing volume of diabetes-related dialysis: A population based study. Nephrol Dial Transplant2004;19: 3098-103.
28. Schroijen MA, van de Luijtgaarden MWM, Noordzij M, et al. Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia 2013;56: 1949-57.